SEB Asienfond ex Japan D vs UBS Lux Equity Fund Biotech USD

SEB Asienfond ex Japan D vs UBS Lux Equity Fund Biotech USD

1. SEB Asienfond ex Japan D

  • Security

    SEB Asienfond ex Japan D USD Utd

  • Fee

    2.31%

  • ISIN

    SE0021150174

  • Holdings

    12

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 12 holdings in SEB Asienfond ex Japan D, where the largest holding is TSMC (9.48), followed by Meituan Class B (3.09) and MediaTek (2.95). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in SEB Asienfond ex Japan D and UBS Lux Equity Fund Biotech USD.

SEB Asienfond ex Japan D UBS Lux Equity Fund Biotech USD
1. Taiwan Semiconductor Manufacturing Company
Taiwan
9.48 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Meituan Class B
China
3.09 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. MediaTek Inc
Taiwan
2.95 %
3. Moderna Inc
9.21 %
4. SK Hynix Inc
South Korea
2.95 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. Samsung Electronics Co Ltd
South Korea
2.73 %
5. AbbVie Inc
USA
5.52 %
6. Tencent
China
2.73 %
6. Gilead Sciences Inc
USA
4.66 %
7. China Construction Bank Corp Class H
China
2.68 %
7. Amgen Inc
4.32 %
8. KB Financial Group Inc
South Korea
2.18 %
8. BioNTech SE
4.13 %
9. Bank of China Hong Kong Holdings Ltd
Hong Kong
2.14 %
9. Karuna Therapeutics Inc
3.75 %
10. Geely Automobile Holdings Ltd
China
2.12 %
10. Royalty Pharma Plc
3.28 %
11. Wistron Corp
Taiwan
2.06 %
-
12. Shanghai Pudong Development Bank Co Ltd
China
2 %
-

The list of fund holdings was last updated on April 17, 2025.